Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Tighter blood pressure control = better outcomes for heart failure patients. A new study found that heart failure patients who kept their systolic blood pressure within the 110–130 mm Hg target range for more time had significantly lower odds of kidney function decline and a reduced risk of death. The findings suggest that tracking "time in target range" could become a valuable tool in managing heart failure care.
For heart failure patients, how long blood pressure stays in the sweet spot may matter just as much as the reading itself. A large prospective cohort study out of China tracked systolic blood pressure (SBP) control in over 2,000 hospitalized heart failure patients and found that spending more time within the 110–130 mm Hg target range was meaningfully linked to better kidney and survival outcomes.
Researchers measured SBP at 1, 6, and 12 months post-discharge and calculated each patient's "time in target range" (TTR). The results were striking: patients in the highest TTR group had significantly lower rates of kidney decline and death compared to those in the lowest group.
By the Numbers:
Why it matters: Heart failure management often focuses on symptoms and hospitalization rates, but this study highlights that sustained blood pressure control — not just spot readings — could be a key lever for protecting kidney function and extending life. TTR may emerge as a practical, prognostic metric in routine HF care.
